Athelas vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
SF healthcare tech with remote patient monitoring devices and AI medical billing for CCM/RPM programs; $132M General Catalyst and Sequoia backed generating $200-300/month per patient in additional practice revenue.
About
Athelas is a San Francisco-based healthcare technology company providing remote patient monitoring (RPM) devices and AI-powered medical billing automation for physicians managing patients with chronic conditions — enabling clinics to capture recurring CMS (Centers for Medicare & Medicaid Services) reimbursement for Chronic Care Management (CCM) and Remote Patient Monitoring programs that most practices fail to bill correctly or at all. Founded in 2016 by Tanay Tandon and Deepika Bodapati and backed with $132 million raised from General Catalyst, Sequoia Capital, and others, Athelas serves 1,000+ healthcare provider organizations with cellular-connected monitoring devices and automated billing workflow.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.